Health Care Update - June 2014 #2

In This Issue:

- Confusion Persists in Anticipation of 340B “Mega-Rule”

- Implementation of the Affordable Care Act

- Other Federal Regulatory Initiatives

- Other Congressional and State Initiatives

- Other Health Care News

- Upcoming Hearings and Markups

- Excerpt from Confusion Persists in Anticipation of 340B “Mega-Rule”:

The 340B drug discount program continues to be one of the most scrutinized and anticipated areas of health policy regulation going into the summer. The 340B program provides discounts between 20 and 50 percent off the cost of pharmaceuticals to providers, such as hospitals and community health centers. While the program was initially created to provide affordable access to providers serving overwhelmingly needy communities, the ACA’s expansion of eligible providers to critical access hospitals (CAHs) and children’s hospitals, among others, has drawn the intense scrutiny of lawmakers and drug manufacturers alike.

Please see full update below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Mintz Levin - Health Law & Policy Matters | Attorney Advertising

Written by:


Mintz Levin - Health Law & Policy Matters on:

Popular Topics
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.